Drugs / ORA·FANGⓇ
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04593446 | Nov 2020 → Dec 2021 | colorectal cancer | National Cancer Center, Korea | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ORA·FANGⓇ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04593446 ↗ |
| Known as | Oral Sulfate Tablet | “Oral Sulfate Tablet(ORA·FANGⓇ)” NCT04593446 ↗ |
| Route | Oral | “receive 14 pills at 8 pm in the evening 2days before the surgery” NCT04593446 ↗ |